- Type / Class
- Equity / Common Stock
- Shares outstanding
- 61,152,075
- Total 13F shares
- 63,798,487
- Share change
- +1,080,403
- Total reported value
- $12,683,838,954
- Put/Call ratio
- 29%
- Price per share
- $198.81
- Number of holders
- 279
- Value change
- +$232,138,786
- Number of buys
- 154
- Number of sells
- 114
Quarterly Holders Quick Answers
What is CUSIP 04351P101?
CUSIP 04351P101 identifies ASND - Ascendis Pharma A/S - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 04351P101:
Top shareholders of ASND - Ascendis Pharma A/S - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
17%
|
10,281,496
|
$1,774,586,210 | — | 30 Jun 2025 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
8.9%
|
5,451,401
|
$940,911,882 | — | 30 Jun 2025 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
8.1%
|
4,980,000
|
$859,548,000 | — | 30 Jun 2025 | |
| JANUS HENDERSON GROUP PLC |
13D/G
13F
|
Company |
7.8%
|
4,323,059
|
$859,467,360 | -$20,821,968 | 30 Sep 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
8%
from 13D/G
|
4,531,724
|
$782,175,562 | — | 30 Jun 2025 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
6.5%
|
3,990,424
|
$688,747,182 | — | 30 Jun 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
13D/G
|
Company |
4.8%
from 13D/G
|
3,583,546
|
$618,521,000 | — | 30 Jun 2025 | |
| Capital International Investors |
13D/G
13F
|
Company |
5.6%
|
3,109,225
|
$548,747,120 | $0 | 30 Jun 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
3.1%
|
1,901,843
|
$328,258,102 | — | 30 Jun 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3.1%
|
1,875,491
|
$323,710,000 | — | 30 Jun 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
2.9%
|
1,753,468
|
$302,648,581 | — | 30 Jun 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.6%
|
963,886
|
$166,366,724 | — | 30 Jun 2025 | |
| Invesco Ltd. |
13F
|
Company |
1.5%
|
947,226
|
$163,491,208 | — | 30 Jun 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.5%
|
918,095
|
$158,463,198 | — | 30 Jun 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
1.4%
|
837,777
|
$144,600,310 | — | 30 Jun 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.96%
|
588,069
|
$101,500,709 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.96%
|
587,342
|
$101,375,229 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.88%
|
538,287
|
$92,908,336 | — | 30 Jun 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.87%
|
530,809
|
$91,618,576 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.77%
|
471,726
|
$81,419,909 | — | 30 Jun 2025 | |
| FIL Ltd |
13F
|
Company |
0.76%
|
464,096
|
$80,102,970 | — | 30 Jun 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.75%
|
459,606
|
$79,327,996 | — | 30 Jun 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.62%
|
377,701
|
$65,191,193 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.5%
|
305,454
|
$52,721,360 | — | 30 Jun 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.48%
|
292,090
|
$50,414,734 | — | 30 Jun 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.45%
|
276,984
|
$47,807,000 | — | 30 Jun 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.43%
|
263,267
|
$45,439,884 | — | 30 Jun 2025 | |
| Q Global Advisors, LLC |
13F
|
Company |
0.42%
|
255,000
|
$44,013,000 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.42%
|
254,785
|
$43,976,004 | — | 30 Jun 2025 | |
| Camber Capital Management LP |
13F
|
Company |
0.41%
|
250,000
|
$43,150,000 | — | 30 Jun 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
0.4%
|
245,943
|
$42,449,762 | — | 30 Jun 2025 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.39%
|
236,570
|
$40,832,014 | — | 30 Jun 2025 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.36%
|
221,754
|
$38,274,740 | — | 30 Jun 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.36%
|
219,118
|
$37,819,767 | — | 30 Jun 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.35%
|
217,000
|
$37,454,200 | — | 30 Jun 2025 | |
| ARS Investment Partners, LLC |
13F
|
Company |
0.34%
|
209,930
|
$36,233,918 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.34%
|
208,141
|
$35,925,136 | — | 30 Jun 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.33%
|
201,044
|
$34,700,194 | — | 30 Jun 2025 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.33%
|
200,000
|
$34,520,000 | — | 30 Jun 2025 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.33%
|
200,257
|
$34,444,204 | — | 30 Jun 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.32%
|
195,115
|
$33,678,283 | — | 30 Jun 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.32%
|
195,108
|
$33,675,641 | — | 30 Jun 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.3%
|
182,558
|
$31,509,511 | — | 30 Jun 2025 | |
| Catalio Capital Management, LP |
13F
|
Company |
0.29%
|
179,926
|
$31,055,228 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.27%
|
165,667
|
$28,594,124 | — | 30 Jun 2025 | |
| Resolute Capital Asset Partners LLC |
13F
|
Company |
0.26%
|
160,672
|
$27,731,987 | — | 30 Jun 2025 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.26%
|
160,110
|
$27,634,986 | — | 30 Jun 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.25%
|
154,176
|
$26,610,000 | — | 30 Jun 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.24%
|
148,497
|
$25,630,583 | — | 30 Jun 2025 | |
| Tri Locum Partners LP |
13F
|
Company |
0.24%
|
147,642
|
$25,483,009 | — | 30 Jun 2025 |
Institutional Holders of Ascendis Pharma A/S - Common Stock (ASND) as of Q3 2025
As of 30 Sep 2025,
Ascendis Pharma A/S - Common Stock (ASND) was held by
279 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,798,487 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., WESTFIELD CAPITAL MANAGEMENT CO LP, Avoro Capital Advisors LLC, FMR LLC, JANUS HENDERSON GROUP PLC, Artisan Partners Limited Partnership, Capital International Investors, T. Rowe Price Investment Management, Inc., MASSACHUSETTS FINANCIAL SERVICES CO /MA/, and WELLINGTON MANAGEMENT GROUP LLP.
This page lists
279
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
245
Q3 2025 holders
279
Holder diff
34
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.